Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.

Abstract

Treatment with the chimeric anti-CD20 monoclonal antibody rituximab induces rapid and long-lasting depletion of circulating B cells. We report the occurrence of enteroviral meningoencephalitis following rituximab therapy in 1 child with immune thrombocytopenia and in 1 adult patient with relapsed B cell lymphoma.

0100200'04'06'08'10'12'14'16
Citations per Year

837 Citations

Semantic Scholar estimates that this publication has 837 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Quartier2003EnteroviralMA, title={Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.}, author={Pierre Quartier and Olivier Tournilhac and Christine Archimbaud and Leila Lazaro and Carine Chaleteix and Pascale Millet and H{\'e}l{\`e}ne Peigue-Lafeuille and S. Buffet Croix Blanche and Alain Fischer and Jean-Laurent Casanova and Philippe Travade and Marc Tardieu}, journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America}, year={2003}, volume={36 3}, pages={e47-9} }